Bulevirtide (Hepcludex) monotherapy significantly reduces the load of hepatitis delta virus (HDV) and is safe in difficult-to-treat patients with compensated cirrhosis and clinically significant ...

The results of two phase 3 trials suggest that investigational drug bepirovirsen reduces HBsAg production, helping the immune ...

September 5, 2008 — The US Food and Drug Administration (FDA) approved yesterday the first nucleic acid test for hepatitis B virus (HBV) that measures blood levels of viral DNA as an estimate of viral ...

Globally, the hepatitis B virus is a major cause of mortality from infectious diseases. Around 250 million people suffer from chronic HBV infections, with the virus being responsible for over one ...

Should Randomized Clinical Trials Be Required for Proton Radiotherapy? A prospective cohort of patients infected with chronic HBV in a surveillance program for HCC since 1997 was studied. Ultrasound ...

Officials attributed part of the increase to expanded screening and said RT-PCR viral load testing facilities are now being revived.

SALT LAKE CITY, April 19, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular ...

Vaccination against hepatitis B is a common recommendation, but what exactly is it preventing? HHS Secretary Robert F. Kennedy Jr. and his advisory group plan to meet this week to discuss and vote on ...

Learn how ALT flares around childbirth may predict earlier HBeAg clearance in women with hepatitis B and what this could mean for care.